FDA CDRH leaders and the entire FDA Office of Media Affairs were reportedly eliminated in the Trump Administration's mass ...

Cognito Therapeutics today announced new data from its OVERTURE feasibility trial evaluating its Spectris neuromodulation ...

Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Bright Uro announced today that it has received FDA 510(k) clearance for its Glean urodynamic analyzer system.

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

Medtronic (NYSE: MDT) recently announced a partnership with Methinks AI to enhance stroke treatment in a number of ...

CMR Surgical announced today that it closed a financing round worth over $200 million in a combination of equity and debt ...

McDonald, a veteran of more than 35 years in medtech, most recently served as CEO of LivaNova. Over six years there, he drove improvements in growth, profitability and shareholder value before ...

Stryker (NYSE: SYK) announced today that it completed the sale of its U.S. spinal implants business to Viscogliosi Brothers.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.